Response to letter to the Editors—Safety of long-term denosumab therapy
Crossref DOI link: https://doi.org/10.1007/s00520-016-3492-8
Published Online: 2016-11-24
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stopeck, Alison T.
Warner, Douglas J.
Funding for this research was provided by:
Amgen
License valid from 2016-11-24